Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma
Conditions: Laryngeal Cancer; Hypopharyngeal Cancer Intervention: Drug: Toripalimab Sponsor: Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Hypopharyngeal Cancer | Laryngeal Cancer | Research